Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · IEX Real-Time Price · USD
5.65
+0.08 (1.44%)
At close: Jul 26, 2024, 4:00 PM
5.74
+0.09 (1.59%)
After-hours: Jul 26, 2024, 6:43 PM EDT
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $464.64 million as of July 26, 2024. Its market cap has decreased by -25.75% in one year.
Market Cap
464.64M
Enterprise Value
202.61M
1-Year Change
-25.75%
Ranking
Category
Stock Price
$5.65
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $464.64M, a decrease of -28.48%. That is a compound annual growth rate of -3.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 458.10M | -44.63% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
| Feb 3, 2016 | 649.70M | - |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oculis Holding AG | 480.59M |
| MaxCyte | 478.81M |
| Heron Therapeutics | 477.57M |
| GRAIL, LLC | 475.98M |
| Aura Biosciences | 467.69M |
| Taysha Gene Therapies | 461.16M |
| Health Catalyst | 458.70M |
| Altimmune | 455.90M |